| Primary |
| Drug Use For Unknown Indication |
45.9% |
| Prophylaxis |
9.9% |
| Infection Prophylaxis |
7.0% |
| Product Used For Unknown Indication |
6.4% |
| Antibiotic Prophylaxis |
4.5% |
| Preoperative Care |
4.2% |
| Surgery |
3.5% |
| Anaesthesia |
2.8% |
| Cellulitis |
2.0% |
| Staphylococcal Infection |
1.7% |
| Infectious Peritonitis |
1.5% |
| Pyrexia |
1.5% |
| Upper Respiratory Tract Infection |
1.3% |
| Induction Of Anaesthesia |
1.2% |
| Infection |
1.2% |
| Tumour Excision |
1.2% |
| Wound Infection |
1.2% |
| Cardiac Operation |
1.0% |
| Pain |
1.0% |
| Perioperative Analgesia |
1.0% |
|
| Rash |
12.6% |
| Anaphylactic Reaction |
12.0% |
| Urticaria |
12.0% |
| Status Epilepticus |
8.7% |
| Hypotension |
7.1% |
| Pyrexia |
5.5% |
| Toxic Epidermal Necrolysis |
5.5% |
| Hepatic Function Abnormal |
3.8% |
| Vomiting |
3.8% |
| Wheezing |
3.8% |
| Tachycardia |
3.3% |
| Anaphylactic Shock |
2.7% |
| Medication Error |
2.7% |
| Pruritus |
2.7% |
| Swelling |
2.7% |
| Anaphylactoid Reaction |
2.2% |
| Liver Disorder |
2.2% |
| Rash Erythematous |
2.2% |
| Stevens-johnson Syndrome |
2.2% |
| White Blood Cell Count Decreased |
2.2% |
|
| Secondary |
| Product Used For Unknown Indication |
34.1% |
| Drug Use For Unknown Indication |
20.4% |
| Anaesthesia |
6.4% |
| General Anaesthesia |
5.7% |
| Pyrexia |
5.0% |
| Induction Of Anaesthesia |
2.8% |
| Ill-defined Disorder |
2.5% |
| Antibiotic Prophylaxis |
2.4% |
| Prophylaxis |
2.4% |
| Premature Rupture Of Membranes |
2.2% |
| Infection |
2.1% |
| Pneumonia |
2.1% |
| Hypertension |
2.0% |
| Pain |
1.9% |
| Constipation |
1.7% |
| Infection Prophylaxis |
1.5% |
| Thrombosis Prophylaxis |
1.4% |
| Rheumatoid Arthritis |
1.3% |
| Bronchopneumonia |
1.2% |
| Endocarditis |
1.1% |
|
| Anaphylactic Shock |
14.9% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
13.7% |
| Rash |
8.3% |
| Renal Failure Acute |
7.7% |
| Toxic Epidermal Necrolysis |
7.7% |
| Tachycardia |
4.8% |
| Pruritus |
4.2% |
| Shock |
4.2% |
| Drug Exposure During Pregnancy |
3.6% |
| Clostridial Infection |
3.0% |
| Colitis Ulcerative |
3.0% |
| Hypersensitivity |
3.0% |
| Pyrexia |
3.0% |
| Rash Maculo-papular |
3.0% |
| Stevens-johnson Syndrome |
3.0% |
| Urticaria |
3.0% |
| Vestibular Disorder |
3.0% |
| Anaphylactoid Shock |
2.4% |
| Bronchospasm |
2.4% |
| Convulsion |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
45.7% |
| Drug Use For Unknown Indication |
20.9% |
| Pain |
3.8% |
| Coronary Artery Bypass |
3.8% |
| Prophylaxis |
3.5% |
| Anaesthesia |
2.6% |
| Hypertension |
2.6% |
| Thrombosis Prophylaxis |
2.3% |
| Renal Transplant |
2.1% |
| Aortic Valve Replacement |
1.3% |
| Antibiotic Prophylaxis |
1.3% |
| Sedation |
1.3% |
| Catheterisation Cardiac |
1.2% |
| Metastases To Bone |
1.2% |
| Infection Prophylaxis |
1.2% |
| Mitral Valve Replacement |
1.2% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.0% |
| Constipation |
1.0% |
| Rheumatoid Arthritis |
0.9% |
| Bacterial Infection |
0.9% |
|
| Pain |
9.7% |
| Vomiting |
9.6% |
| Injury |
9.2% |
| Pulmonary Embolism |
6.4% |
| Unevaluable Event |
6.0% |
| Weight Decreased |
5.5% |
| Anhedonia |
5.0% |
| Macular Oedema |
4.9% |
| Fear |
4.7% |
| Anxiety |
4.4% |
| Renal Failure |
4.4% |
| Respiratory Failure |
3.9% |
| Renal Impairment |
3.7% |
| Unresponsive To Stimuli |
3.5% |
| Emotional Distress |
3.4% |
| Renal Failure Acute |
3.4% |
| Urinary Tract Infection |
3.4% |
| White Blood Cell Count Increased |
3.2% |
| Sepsis |
3.0% |
| Ventricular Tachycardia |
2.9% |
|
